So it's an orgy! Whoo Hoo, just like the old days. We all get oral! What will the product percentages be? What will the payer contracts be? Will they price it like an oral or like a GLP1? How will we maintain our insulin business? So many products declining. Can we really make this company soar on the wings on 1 product?
There is no way they will have everyone sell the oral, when the BIG O is doing so well. Would be insanity. Sell the bird in hand!!!!
Luckily for us, there is more than just your pod at this company. Pretty sure no big decisions are being made based upon you and you alone.
Given the FDA statement.. First regional realignments. Then, then jobs go to lower paying reps to offset pricing cuts about to come. https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-continued-efforts-bring-competition-insulin
HR insider here...major realignments Q4....it is confirmed....make future plans accordingly...Re32Df...
HR insider here....large realignment/layoffs Q4....it is confirmed....make future plans accordingly...Re43 Sax...
What on earth are you talking about? These are not buy-and-bill products FYI. He is probably talking about some other inj therapies which he makes money from via buy-and-bill ( the office purchases product and supplies to the pt. then bills insurance directly, netting them a spread or profit on such goods). Also to the other poster nice work bringing up a breaking news story from April 2.